| Singer, Nora G |
| Recruiting | 3 | 924 | Canada, US | targeted synthetic DMARD class, non-TNFi-biologic class | University of Alabama at Birmingham, Patient-Centered Outcomes Research Institute | Rheumatoid Arthritis | 02/27 | 12/28 | | |
| Recruiting | 3 | 406 | Europe, Canada, Japan, US, RoW | Ianalumab, VAY736, Placebo | Novartis Pharmaceuticals, Novartis Pharma AG | Systemic Lupus Erythematosus | 01/27 | 04/29 | | |
| Active, not recruiting | 2 | 964 | US | Experimental: Paxlovid 25 day dosing, Experimental: Paxlovid 15 day dosing, Placebo Comparator: Control | Kanecia Obie Zimmerman | Long COVID, Long Covid19 | 08/24 | 03/25 | | |
NCT03186417: Mesenchymal Stem Cells in Early Rheumatoid Arthritis |
|
|
| Terminated | 1 | 10 | US | 2 million hMSC/kg, 4 million hMSC/kg, 6 million hMSC/kg, placebo | MetroHealth Medical Center, National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) | Rheumatoid Arthritis | 04/23 | 05/23 | | |
NCT05172024: Understanding the Long-term Impact of COVID-19 in Adults (RECOVER) |
|
|
| Active, not recruiting | N/A | 15178 | US | | NYU Langone Health, National Heart, Lung, and Blood Institute (NHLBI) | SARS-CoV2 Infection | 04/25 | 05/25 | | |
NCT02418442: Observational Study of Pediatric Rheumatic Diseases: The CARRA Registry |
|
|
| Recruiting | N/A | 20000 | Europe, Canada, US, RoW | | Duke University, Childhood Arthritis and Rheumatology Research Alliance | Rheumatic Joint Disease | 06/28 | 12/28 | | |
NCT05934149: Lupus Landmark Study: A Prospective Registry and Biorepository |
|
|
| Recruiting | N/A | 3500 | Canada, US | | Lupus Research Alliance | Systemic Lupus Erythematosus (SLE), Lupus Nephritis, Neuropsychiatric Systemic Lupus Erythematosus | 12/33 | 12/33 | | |
| Lesko, Mary |
CHANGE AFIB, NCT05130268: Early Dronedarone Versus Usual Care to Improve Outcomes in Persons With Newly Diagnosed Atrial Fibrillation |
|
|
| Completed | 4 | 339 | US | Dronedarone, Multaq | American Heart Association, Duke Clinical Research Institute, Sanofi | Atrial Fibrillation | 01/24 | 06/24 | | |
GenePHIT, NCT05598333: Phosphatase Inhibition by Intracoronary Gene Therapy in Subjects with Non-Ischemic NYHA Class III Heart Failure |
|
|
| Recruiting | 2 | 150 | US | AB-1002, Gene Therapy, NAN-101 | Asklepios Biopharmaceutical, Inc. | Congestive Heart Failure | 10/26 | 12/30 | | |
SUMMIT, NCT03433274: Clinical Trial to Evaluate the Safety and Effectiveness of Using the Tendyne Transcatheter Mitral Valve System for the Treatment of Symptomatic Mitral Regurgitation |
|
|
| Recruiting | N/A | 958 | Canada, US | Tendyne Mitral Valve System, MitraClip System | Abbott Medical Devices | Mitral Regurgitation, Mitral Insufficiency, Mitral Valve Insufficiency, Cardiovascular Diseases, Valve Disease, Heart, Heart Valve Diseases, Functional Mitral Regurgitation, Degenerative Mitral Valve Disease | 05/24 | 06/28 | | |
ECLIPSE, NCT03108456: Evaluation of Treatment Strategies for Severe CaLcIfic Coronary Arteries: Orbital Atherectomy vs. Conventional Angioplasty Technique Prior to Implantation of Drug-Eluting StEnts: The Trial |
|
|
| Active, not recruiting | N/A | 2005 | US | Orbital Atherectomy, Balloon | Abbott Medical Devices, Cardiovascular Research Foundation, New York | Coronary Artery Disease, Ischemic Heart Disease, Non ST Segment Elevation Myocardial Infarction | 06/24 | 06/25 | | |
